REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 179 filers reported holding REGENXBIO INC in Q2 2018. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $533,304 | -57.1% | 32,400 | -47.9% | 0.00% | -50.0% |
Q2 2023 | $1,243,518 | -33.6% | 62,207 | -37.2% | 0.00% | -42.9% |
Q1 2023 | $1,873,981 | -18.2% | 99,100 | -1.9% | 0.01% | -12.5% |
Q4 2022 | $2,291,066 | +42.1% | 101,017 | +65.6% | 0.01% | +14.3% |
Q3 2022 | $1,612,000 | +25.5% | 61,000 | +17.3% | 0.01% | +40.0% |
Q2 2022 | $1,284,000 | +390.1% | 52,000 | +558.2% | 0.01% | +400.0% |
Q1 2022 | $262,000 | +30.3% | 7,900 | +33.9% | 0.00% | 0.0% |
Q1 2021 | $201,000 | -88.1% | 5,900 | -84.2% | 0.00% | -85.7% |
Q4 2020 | $1,692,000 | +178.7% | 37,300 | +68.9% | 0.01% | +250.0% |
Q3 2020 | $607,000 | -79.1% | 22,089 | -72.0% | 0.00% | -86.7% |
Q2 2020 | $2,904,000 | +38.5% | 78,843 | +93.3% | 0.02% | +87.5% |
Q2 2019 | $2,096,000 | -32.2% | 40,794 | -24.4% | 0.01% | -33.3% |
Q1 2019 | $3,093,000 | +43.9% | 53,954 | +5.3% | 0.01% | +20.0% |
Q4 2018 | $2,150,000 | -3.7% | 51,239 | +73.3% | 0.01% | +25.0% |
Q3 2018 | $2,233,000 | +556.8% | 29,568 | +524.1% | 0.01% | +700.0% |
Q2 2018 | $340,000 | – | 4,738 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 839,139 | $35,177,000 | 6.39% |
Sonic Fund II, L.P. | 188,786 | $7,914,000 | 4.47% |
ArchPoint Investors | 297,355 | $12,465,000 | 3.73% |
Redmile Group, LLC | 2,008,001 | $84,175,000 | 1.47% |
RTW INVESTMENTS, LP | 1,845,366 | $77,358,000 | 1.17% |
WS MANAGEMENT LLLP | 210,729 | $8,834,000 | 0.94% |
FRAZIER MANAGEMENT LLC | 235,809 | $9,885,000 | 0.79% |
Integral Health Asset Management, LLC | 55,000 | $2,306,000 | 0.66% |
Sofinnova Investments, Inc. | 127,593 | $5,349,000 | 0.32% |
HHLR ADVISORS, LTD. | 456,000 | $19,116,000 | 0.25% |